We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Growth of AIDS Virus Enhanced by Methamphetamine

By Biotechdaily staff writers
Posted on 20 Jun 2002
Research done on a feline model that mimics human AIDS has shown that exposure to methamphetamine increases by as much as 15-fold the ability of the feline immunodeficiency virus (FIV) to replicate in the cat brain. More...
In the study, which was published in the June 2002 issue of the Journal of NeuroVirolgy, cat brain tissues were exposed to a concentration of methamphetamine equal to the average level in an adult human abuser's bloodstream.

"We found that after about two weeks of chronic methamphetamine exposure, the ability of these infected cell lines to mass-produce virus increases dramatically,” explained Dr. Michael Podell of Ohio State University (Columbus, USA), professor of veterinary clinical sciences and neurosciences.

Before beginning the methamphetamine experiments the investigators established a system for infecting astrocytes isolated from feline brain tissue with the FIV virus. They found that initial infection required that the astrocytes be associated with peripheral blood mononuclear cells (PBMCs). Once it had infected the astrocytes, the virus began to rapidly reproduce, an observation that was contrary to the accepted belief that FIV resulted only in a latent infection.

"We found that the reason the virus multiplies so rapidly is that it mutates into a different strain,” Dr. Podell said, one that is not dependent on the presence of PBMCs. This virus strain appears to be completely independent of any immune system interaction. "That means that any drugs intended to interfere with, or influence the immune system may have absolutely no effect on the astrocyte infection in the brain,” added Dr. Podell. Infection by both virus strains was dependent upon a functional astrocyte CXCR4 receptor.

Methamphetamine significantly increased FIV replication in feline astrocytes for cell-associated infection only, with no effect on peripheral blood mononuclear cells. This viral replication was related to proviral copy number, suggesting that the effect of methamphetamine was at the viral entry or integration into host genome levels, but not at the translational level. Thus, FIV infection of the brain in the presence of methamphetamine resulted in enhanced astrocyte viral replication, producing a more rapid and increased brain viral load.



Related Links:
Ohio State University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.